Fennec Pharmaceuticals In... (FENC)

AI Score

Unlock

5.19

-0.40 (-7.16%)

At close: Apr 04, 2025, 3:32 PM

Fennec Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Jun 30, 2004	Jun 30, 2003	Jun 30, 2002	Jun 30, 2001	Jun 30, 2000
Cash & Equivalents	26.63M	13.27M	23.77M	21.1M	30.34M	13.65M	22.78M	28.26M	3.93M	942K	2.31M	1.66M	2.3M	5.3M	5.95M	685K	5.35M	16.16M	5.67M	11.97M	13.67M	2.15M	207.06K	9.35M	111.12K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.18M	7.11M	n/a	5.37M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	822K	6K	211K	27K	n/a	262K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	440K	n/a	19.64M	21.84M	n/a	n/a	n/a
Receivables	12.88M	8.81M	1.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	69K	139K	185K	103K	144K	270.42K	22.27K	138.43K	138.59K	29.87K
Inventory	1.06M	2.16M	576K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	75K	123K	185K	94K	59K	151.12K	328.88K	251.95K	0.00	n/a
Other Current Assets	466K	44K	63K	253K	276K	8K	1K	13K	3K	1K	17K	8K	6K	19K	8K	4K	28K	84K	86K	52K	507K	452.31K	218.26K	416.42K	294.89K
Total Current Assets	44.12M	26.86M	26.73M	22.39M	31.42M	13.88M	22.95M	28.4M	3.97M	1.02M	2.37M	1.75M	2.37M	5.35M	5.99M	833K	5.64M	16.56M	5.89M	13.4M	21.68M	3.33M	6.18M	9.94M	435.87K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	421K	648K	293K	892K	420.33K	486.27K	632.91K	519.99K	207.32K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.96M	14.15M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	822K	6K	211K	27K	n/a	262K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	421K	648K	10.69M	15.05M	20.06M	22.33M	632.91K	519.99K	207.32K
Total Assets	44.95M	26.86M	26.94M	22.41M	31.42M	14.15M	22.95M	28.4M	3.97M	1.02M	2.37M	1.75M	2.37M	5.35M	5.99M	833K	6.06M	17.21M	16.58M	28.45M	41.73M	25.66M	6.82M	10.46M	643.19K
Account Payables	2.88M	3.78M	2.39M	777K	1.57M	1.61M	1.03M	855K	244K	297K	308K	212K	259K	342K	272K	318K	547K	532K	2.07M	1.39M	1.48M	1.48M	1.04M	635.52K	441.27K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24.64K	24.64K
Other Current Liabilities	614K	n/a	n/a	n/a	n/a	n/a	n/a	167K	33K	82K	1.32M	2.86M	6.64M	5.08M	10.45M	32K	n/a	40K	n/a	n/a	665.83K	-483	47.51K	-134.9K	59.34K
Total Current Liabilities	6.92M	7.55M	4.61M	1.65M	2.35M	2.27M	1.64M	1.64M	402K	471K	1.76M	3.21M	7.32M	5.47M	10.92M	420K	2.43M	2.4M	4.7M	2.66M	1.48M	1.09M	694.09K	525.25K	479.51K
Long-Term Debt	19.34M	30.93M	24.9M	4.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	33.38K
Other Long-Term Liabilities	24.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7K	577K	659K	665K	550K	92.07K	1.32M	41.95K	110.15K	76.77K
Total Long-Term Liabilities	43.9M	30.93M	24.9M	4.99M	n/a	n/a	1.03M	855K	244K	297K	308K	212K	259K	342K	272K	7K	577K	659K	4.3M	5.72M	7.26M	9.26M	41.95K	110.15K	116.95K
Total Liabilities	50.45M	38.49M	29.51M	6.64M	2.35M	2.27M	1.64M	1.64M	402K	471K	1.76M	3.21M	7.32M	5.47M	10.92M	427K	3.01M	3.06M	9M	8.39M	8.73M	10.35M	736.04K	635.41K	596.46K
Total Debt	19.34M	30.95M	24.9M	4.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	33.41K	59K
Common Stock	145.61M	144.31M	142.59M	140.8M	140.73M	106.39M	106.39M	103.05M	74.52M	69.15M	68.66M	66.79M	65.95M	65.95M	64.93M	64.93M	64.93M	64.93M	46.49M	41.27M	48.34M	n/a	n/a	n/a	n/a
Retained Earnings	-219.68M	-219.25M	-203.2M	-179.49M	-162.14M	-144.03M	-131.26M	-121.37M	-114.32M	-111.53M	-110.87M	-108.7M	-110.54M	-105.38M	-108.81M	-100.99M	-97.98M	-84.38M	-71.5M	-52.4M	-25.49M	-16.58M	-9.1M	-5.4M	-3.01M
Comprehensive Income	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	5.85M	5.85M	22.23M	12.93M	n/a	n/a	n/a
Shareholders Equity	-5.51M	-11.62M	-2.57M	15.77M	29.07M	11.88M	21.31M	26.76M	3.57M	548K	613K	-1.46M	-4.96M	-120K	-4.92M	406K	3.05M	14.15M	7.58M	20.06M	33M	15.31M	6.08M	9.82M	46.73K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.18M	7.11M	n/a	5.37M	n/a	n/a